A PET (Positron Emission Tomography) production centre is a unique environment: it produces short-lived radioactive drugs used within hours of synthesis for oncological, neurological and cardiological diagnosis.
The production of FDG, FCholine or FDOPA requires a cyclotron, radiation shielding, automated chemistry modules and real-time quality control systems. Each batch must be certified before release — within timeframes constrained by radioactive decay.
Whether it's a new centre under creation, a compliance audit, an extension project or resolving a recurring technical problem, Nucleon Partners brings independent, operational and results-oriented external expertise.